Rv1694 - c.201_202dupGC
Drug resistance types
0 Sensitive
0 RR-TB
0 HR-TB
5 MDR-TB
27 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.3.3 | 19 |
| lineage2.2.1 | 7 |
| lineage4.8 | 1 |
| lineage2.2.2 | 3 |
| lineage4.2.1 | 2 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 32 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR1172130 | Pre-XDR-TB | lineage4.3.3 | None | ERR8665559 | Pre-XDR-TB | lineage2.2.1 | None | SRR18715069 | Pre-XDR-TB | lineage4.3.3 | None | ERR8665629 | Pre-XDR-TB | lineage2.2.1 | None | SRR1163338 | Pre-XDR-TB | lineage4.3.3 | None | ERR8665630 | Pre-XDR-TB | lineage2.2.1 | None | SAMN02419622 | Pre-XDR-TB | lineage4.3.3 | by | SRR29274021 | MDR-TB | lineage4.8 | None | SAMN02419626 | Pre-XDR-TB | lineage4.3.3 | by | SAMN02419654 | Pre-XDR-TB | lineage4.3.3 | by | ERR3132302 | MDR-TB | lineage2.2.2 | None | ERR4797523 | Pre-XDR-TB | lineage2.2.1 | in | SRR1169014 | Pre-XDR-TB | lineage4.3.3 | None | SRR13870386 | Pre-XDR-TB | lineage4.3.3 | None | SRR1163385 | Pre-XDR-TB | lineage4.3.3 | None | ERR1213849 | MDR-TB | lineage2.2.2 | kr | ERR2516619 | Pre-XDR-TB | lineage4.3.3 | pe | SRR1163412 | Pre-XDR-TB | lineage4.3.3 | None | SRR1163189 | Pre-XDR-TB | lineage4.3.3 | None | SRR6356977 | Pre-XDR-TB | lineage2.2.1 | None | SRR13232523 | Pre-XDR-TB | lineage2.2.1 | None | SRR1162996 | Pre-XDR-TB | lineage4.3.3 | None | SRR13232525 | Pre-XDR-TB | lineage2.2.1 | None | ERR2516455 | Pre-XDR-TB | lineage4.3.3 | pe | SRR17657931 | MDR-TB | lineage2.2.2 | None | ERR8665620 | Pre-XDR-TB | lineage4.3.3 | None | SRR14801706 | MDR-TB | lineage4.2.1 | None | SRR13232712 | Pre-XDR-TB | lineage4.3.3 | None | SRR13232693 | Pre-XDR-TB | lineage4.3.3 | None | SRR1163106 | Pre-XDR-TB | lineage4.3.3 | None | SRR28394043 | Pre-XDR-TB | lineage4.3.3 | None | SRR3743402 | Pre-XDR-TB | lineage4.2.1 | None |
|---|
